fbpx

#NextCell Pharma

Cellaviva Sverige April 27, 2021

Pediatric diabetes study with stem cells approved

Uppsala University Hospital and the principal investigator, Professor Per-Ola Carlsson, have been granted approval from the Medical Products Agency and the Swedish Ethical Review Authority to conduct a clinical drug trial with ProTrans™ to treat children and adolescents with type-1 diabetes. The study is a phase I / II study with a total of 66 patients.

Cellaviva Sverige February 2, 2021
Canadian Trial for ProTrans in COVID-19

Canadian Trial for ProTrans in COVID-19

TUE, FEB 02, 2021 15:50 CET NextCell Pharma AB (“NextCell”) today announces that Health Canada and the McGill University Health Centre Research Ethics Board have authorized the clinical trial entitled...

Prepare for the summer
Prepare for the summer

Are you expecting a summer child with a due date in the holiday season?

If you are planning to order our help with the collection, make sure to order well in advance of your due date.